1-7 of 7
| Supplier | Product name | Cat.no. | Pack size | Price | ||
|---|---|---|---|---|---|---|
 |
In vivo Grade Recombinant Humanized HEL D1.3 Human IgG2 Isotype Control Antibody | PA007153.h2-5MG | 667,00 |
|
||
|
|
In vivo Grade Recombinant Humanized HyHEL-10 Human IgG2 Isotype Control Antibody | PA007154.h2-5MG | 667,00 |
|
||
|
|
In vivo Grade Recombinant HyHEL-10 Hamster IgG2 Isotype Control Antibody | PA007154.hs2-5MG | 667,00 |
|
||
|
|
Cetuximab Biosimilar, Human IgG2 | C002P.h2-0.5MG | 440,00 |
|
||
|
|
Denosumab Biosimilar, Human IgG1 | C004P.h1-0.5MG | 440,00 |
|
||
|
|
Denosumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C004P.LA-0.5MG | 440,00 |
|
||
|
|
Denosumab Biosimilar, N297A Mutant | C004P.NA-0.5MG | 440,00 |
|
1-7 of 7
Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch
Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00
Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch
Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern
© Copyright 2021 Lucerna-Chem AG, Switzerland